Crossref
FDA Approves New Drug to Treat Herpes Simplex Virus Lesions
JAMA · 30.10.2026
DOI: 10.1001/jama.2026.20034 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, online erschienen am 30.10.2026. Verfasst von Sari Richmond.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Richmond, S. (2026). FDA Approves New Drug to Treat Herpes Simplex Virus Lesions. JAMA. https://doi.org/10.1001/jama.2026.20034
Vancouver
Richmond S. FDA Approves New Drug to Treat Herpes Simplex Virus Lesions. JAMA. 2026. doi:10.1001/jama.2026.20034
BibTeX
@article{Richmond2026,
author = {Richmond, Sari},
title = {FDA Approves New Drug to Treat Herpes Simplex Virus Lesions},
journal = {JAMA},
year = {2026},
doi = {10.1001/jama.2026.20034}
}
EUVIMED